These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8414779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [Abstract] [Full Text] [Related]

  • 4. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [Abstract] [Full Text] [Related]

  • 5. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
    Thorburn K.
    Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
    [Abstract] [Full Text] [Related]

  • 6. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course.
    Wilkesmann A, Ammann RA, Schildgen O, Eis-Hübinger AM, Müller A, Seidenberg J, Stephan V, Rieger C, Herting E, Wygold T, Hornschuh F, Groothuis JR, Simon A, DSM RSV Ped Study Group.
    Pediatr Infect Dis J; 2007 Jun; 26(6):485-91. PubMed ID: 17529864
    [Abstract] [Full Text] [Related]

  • 7. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA, Cosgrove JF, MacMahon P.
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children].
    Bergsträsser E, Zbinden R, Minder C, Gnehm HE.
    Klin Padiatr; 1998 Dec; 210(6):418-21. PubMed ID: 9871899
    [Abstract] [Full Text] [Related]

  • 10. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy.
    Medici MC, Arcangeletti MC, Merolla R, Chezzi C, Osservatorio VRS Study Group.
    Acta Biomed; 2004 Apr; 75(1):26-33. PubMed ID: 15315084
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of infants with RSV infection: a retrospective analysis of the season 1998/99].
    Schauer U, Rieger CH.
    Klin Padiatr; 2002 Apr; 214(1):37-40. PubMed ID: 11823952
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
    Howidi M, Rajah J, Abushrar Z, Parsons H.
    J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.